
Retinaldehyde: Some formulas improve photoaged texture and pigmentation over months. Salicylic Acid: Helps unclog acne-prone skin; stronger products treat selected thickened skin lesions.


Consider for photoaged texture; introduce slowly and judge the complete formula.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Can you use both?
Use a salicylic cleanser rather than a leave-on, or alternate nights.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.












Converts to retinoic acid: Skin enzymes can activate retinaldehyde. Changes cell activity: Retinoic acid acts through nuclear receptors.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Loosens outer skin cells: Salicylic acid promotes keratin shedding. Helps clear follicular plugs: Its acne role depends on strength and vehicle.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
0.05% and 0.1% retinaldehyde creams have been compared in a controlled photoaging trial. These percentages cannot be directly compared with retinol or tretinoin.
0.05%
0.1%
Lower studied retinal strength
A cream studied for skin texture and hydration. The result applies to that finished formula.
Higher studied retinal strength
Also studied for photoaging; not better for every measured outcome. Tolerance still determines whether a product suits you.
Choosing a strength: Choose retinaldehyde for its own formula and instructions, not a retinol-to-retinal conversion chart.
Higher strengths: A higher percentage may be harder to tolerate. Stronger products sold commercially do not automatically have stronger comparative clinical evidence.
Formula matters: Encapsulation, stability and the cream or serum base affect delivery. A percentage alone is not a measure of how much reaches skin cells.
The percentage depends on the job: 0.5–2% for OTC acne care, 20–30% in studied office peels, and up to 40% in labeled wart patches. These are different treatments, not steps to work through.
0.5–2%
1.8–3%
5–17%
20–30%
12–40%
Everyday acne care
For blackheads, whiteheads and acne in washes or leave-on products. Follow the product label; dryness or stinging can limit use.
Scalp scale
In labeled treatments for dandruff, seborrheic dermatitis or psoriasis. Helps loosen scale; follow the scalp product’s directions.
Liquid wart removers
For common or plantar warts; 17% is one labeled option. Apply only to the wart, avoiding surrounding healthy skin. Not for facial acne.
Professional office peels
A studied range for clinician-applied peels, including acne treatments. Not for routine home use. Formula, layers and contact time affect the burn risk.
Wart patches and plasters
For common or plantar warts, depending on the label; 40% is a labeled option. Treat the wart only. These are not facial skincare products.
Choosing a strength: Choose for the diagnosis, body area and product type. Facial acne care, scalp products, wart treatments and office peels are not interchangeable.
Higher strengths: High-strength peels can cause burns, scarring and lasting skin-color changes. Wart removers are not for facial or genital warts, irritated or infected skin. Do not self-treat warts with these products if you have diabetes or poor circulation.
Formula matters: The percentage alone does not show how deeply a treatment acts. The base formula, contact time, number of peel layers and whether the product is washed off all matter. Follow the specific label or clinician’s directions.
Approximate windows, not promises.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Dryness, stinging and peeling can occur; avoid irritated areas.
May sting, peel or dry skin; avoid large areas, broken skin and known salicylate allergy without advice.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Retinoids are conventionally stopped in pregnancy and while trying to conceive. Ask the doctor managing your pregnancy. Azelaic acid is the usual alternative.
Over-the-counter strengths on the face are generally considered acceptable, but confirm with the doctor managing your pregnancy. High-strength peels and large body areas are avoided.
On the skin. The finished product delivers retinaldehyde in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. Skin can convert retinaldehyde into retinoic acid.
Skin response. Skin can convert retinaldehyde into retinoic acid, which influences cell activity through retinoid receptors.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers salicylic acid in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Promotes shedding of outer cells and helps clear follicular plugs; concentration and vehicle set its use.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider for photoaged texture; introduce slowly and judge the complete formula.
A 40-woman trial compared two active strengths without a retinoid-free vehicle group. It supports cautious formula-specific claims, not guaranteed superiority to retinol or acne medicines.
Choose for blackheads and clogged pores; use the strength labelled for that area.
Acne guidelines give a conditional recommendation. High-strength wart treatments and 30% peels are distinct interventions; their evidence cannot justify high-strength facial home use.
Sources